logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Unresectable Hepatocellular Carcinoma

    FiltersReset Filters
    6 results

    • avastin

      (bevacizumab)
      Genentech, Inc.
      Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.

    • imfinzi

      (Durvalumab)
      AstraZeneca Pharmaceuticals LP
      Usage: IMFINZI is indicated for various cancers, including resectable non-small cell lung cancer (NSCLC), unresectable Stage III NSCLC, small cell lung cancer (SCLC), biliary tract cancer, hepatocellular carcinoma, advanced or recurrent endometrial cancer, and muscle invasive bladder cancer in combination with other treatments.

    • imjudo

      (tremelimumab)
      AstraZeneca Pharmaceuticals LP
      Usage: IMJUDO is indicated for the treatment of adult patients with unresectable hepatocellular carcinoma in combination with durvalumab. It is also used with durvalumab and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer who lack sensitizing EGFR mutations or ALK genomic aberrations.

    • lenvima

      (Lenvatinib)
      Eisai Inc.
      Usage: LENVIMA is indicated for treating adult patients with radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (in combination with pembrolizumab or everolimus), unresectable hepatocellular carcinoma, and advanced endometrial carcinoma (with pembrolizumab) not amenable to curative surgery or radiation.

    • sorafenib

      (sorafenib)
      TWi Pharmaceuticals USA, Inc.
      Usage: Sorafenib tablets are indicated for unresectable hepatocellular carcinoma (HCC) and for locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.

    • sorafenib

      (sorafenib)
      Yabao Pharmaceutical Co., Ltd. Beijing
      Usage: Sorafenib tablets are indicated for patients with unresectable hepatocellular carcinoma (HCC) and those with locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.